{{Rsnum
|rsid=2270628
|Chromosome=7
|position=45909971
|Orientation=plus
|GMAF=0.2365
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 64.6 | 32.7 | 2.7
| HCB | 65.7 | 30.7 | 3.6
| JPT | 64.6 | 34.5 | 0.9
| YRI | 29.9 | 57.8 | 12.2
| ASW | 29.8 | 59.6 | 10.5
| CHB | 65.7 | 30.7 | 3.6
| CHD | 59.6 | 37.6 | 2.8
| GIH | 82.2 | 17.8 | 0.0
| LWK | 33.9 | 47.7 | 18.3
| MEX | 60.3 | 36.2 | 3.4
| MKK | 48.7 | 41.7 | 9.6
| TSI | 72.5 | 26.5 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19858071
|Title=Common Genetic Variation in IGF1, IGFBP1, and IGFBP3 and Ovarian Cancer Risk
|OA=1
}}

{{PMID|17300730|OA=1
}} Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.

{{PMID|17903296|OA=1
}} Genome-wide association with bone mass and geometry in the Framingham Heart Study.

{{PMID|18596909|OA=1
}} IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).

{{PMID|19240240|OA=1
}} IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women.

{{PMID|19551864|OA=1
}} Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.

{{PMID|19603096|OA=1
}} An analysis of growth, differentiation and apoptosis genes with risk of renal cancer.

{{PMID Auto
|PMID=24938707
|Title=Insulin-like growth factor binding protein-3 (IGFBP-3) genetic variant and the risk of esophageal squamous cell carcinoma in a Chinese population
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}